ArticleBiomolecules2024

Exploring the Biological Activity of a Humanized Anti-CD99 ScFv and Antibody for Targeting T Cell Malignancies.

Nuchjira Takheaw et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.